Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Challenger's Enterprise Value for the quarter that ended in Dec. 2025 was A$-2,142 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Challenger's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$1,244 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Challenger EV-to-EBIT Related Terms
Challenger EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Challenger's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Insurance - Life subindustry, Challenger's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Challenger EV-to-EBIT vs Insurance Industry
For the Insurance industry and Financial Services sector, Challenger's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Challenger's EV-to-EBIT falls into.
Challenger's current Enterprise Value is A$-1,355 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Challenger's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$1,244 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Challenger (ASX:CGF) has a EV-to-EBIT of -1.09 as of Jul. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Challenger and its competitors. According to the industry distribution chart, Challenger ranks #8 out of 347 companies in the Insurance industry, placing it in the top 2.3%.
Is Challenger's EV-to-EBIT too high?
Challenger's current EV-to-EBIT is -1.09. Based on the distribution chart, Challenger ranks #8 out of 347 companies in the Insurance industry, which is in the top quartile — a strong position relative to peers. Overall, Challenger has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Challenger's EV-to-EBIT compare to AFL and MET?
According to the Insurance industry distribution chart, Challenger ranks #8 out of 347 companies for EV-to-EBIT. This places Challenger in the top 2% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 8.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for an Insurance company?
The median EV-to-EBIT among Insurance companies is 8.70, based on 347 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Challenger and its competitors. For the Insurance industry, the median EV-to-EBIT is 8.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Challenger's current EV-to-EBIT is -1.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Challenger stock overvalued right now?
Based on GuruFocus' analysis, Challenger (ASX:CGF) is currently considered Significantly Overvalued. The stock's GF Value™ is A$4.01, compared to a current price of A$10.67 — trading 166.1% above its estimated fair value. The current EV-to-EBIT is -1.09. Challenger's overall GF Score™ is 55/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Challenger (ASX:CGF), the current EV-to-EBIT is -1.09 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Challenger (ASX:CGF) Overvalued in 2026?
Based on GuruFocus' analysis, Challenger stock appears to be overvalued.
The current stock price of A$10.67 is trading 166.1% above its estimated GF Value™ of A$4.01.
GuruFocus considers Challenger to be Significantly Overvalued.
Key valuation signals for ASX:CGF:
EV-to-EBIT: -1.09
GF Value™: A$4.01 vs. price of A$10.67 (166.1% above fair value)
No single metric tells the full story. See the ASX:CGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Challenger's core business is selling annuity products in the Australian retirement market and, since November 2016, selling Australian dollar-denominated annuities into Japan's large retirement market. The firm's annuity products provide investors guaranteed regular payments over an agreed term for an upfront lump sum investment and is designed primarily to protect investors from the longevity risk of outliving their savings. Challenger also operates a funds management business, Fidante Partners, which has minority stakes in several boutique global investment managers, and Challenger Investment Management, which primarily manages investments supporting its annuities business.
55GF Score
Get the complete analysis for ASX:CGF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CGF has been successfully added to your 
